AAAAAA

   
Results: 1-24 |
Results: 24
IRINOTECAN-RELATED CHOLINERGIC SYNDROME INDUCED BY COADMINISTRATION OF OXALIPLATIN
Authors: CVITKOVIC E MARTY M WASSERMAN E CUVIER C GOLDWASSER F MISSET JL
Citation: E. Cvitkovic et al., IRINOTECAN-RELATED CHOLINERGIC SYNDROME INDUCED BY COADMINISTRATION OF OXALIPLATIN, Journal of the National Cancer Institute, 90(13), 1998, pp. 1016-1017
OXALIPLATINE (L-OHP) CPT11 COMBINATION EVERY 2 WEEKS - RESULTS OF AN ONGOING PHASE-I STUDY IN ADVANCED DIGESTIVE MALIGNANCIES/
Authors: GOLDWASSER F GROSS M CHOUAKI N BUTHAUD X RIOFRIO M TIGAUD JM RISSE ML MISSET JL CVITKOVIC E
Citation: F. Goldwasser et al., OXALIPLATINE (L-OHP) CPT11 COMBINATION EVERY 2 WEEKS - RESULTS OF AN ONGOING PHASE-I STUDY IN ADVANCED DIGESTIVE MALIGNANCIES/, Annals of oncology, 9, 1998, pp. 234-234
PRECLINICAL SYNERGY OF OXALIPLATIN IN COMBINATION WITH OTHER ANTITUMOR AGENTS
Authors: FAIVRE S RAYMOND E RIXE O GOLDWASSER F MANGOLD GL VONHOFF DD JUNIEWICZ P CVITKOVIC E
Citation: S. Faivre et al., PRECLINICAL SYNERGY OF OXALIPLATIN IN COMBINATION WITH OTHER ANTITUMOR AGENTS, Annals of oncology, 9, 1998, pp. 627-627
ECTEINASCIDIN-743 (ET-743) 24 HOURS CONTINUOUS-INFUSION (CI) - CLINICAL AND PHARMACOKINETIC PHASE-I STUDY PROGRESSIVE REPORT
Authors: RIOFRIO M TAAMMA A MCKRANTER B GOLDWASSER F JIMENO J JASMIN C MISSET JL CVITKOVIC E
Citation: M. Riofrio et al., ECTEINASCIDIN-743 (ET-743) 24 HOURS CONTINUOUS-INFUSION (CI) - CLINICAL AND PHARMACOKINETIC PHASE-I STUDY PROGRESSIVE REPORT, Annals of oncology, 9, 1998, pp. 639-639
INTERACTION BETWEEN TOPOTECAN AND CYCLOSPORINE - CLINICAL-RESULTS ANDPHARMACOKINETICS OVER 3 COURSES
Authors: GROSS M LOKIEC F LEMOINE A CASTAING D SAMUEL D LEVI F MISSET JL GOLDWASSER F
Citation: M. Gross et al., INTERACTION BETWEEN TOPOTECAN AND CYCLOSPORINE - CLINICAL-RESULTS ANDPHARMACOKINETICS OVER 3 COURSES, Annals of oncology, 9, 1998, pp. 668-668
TOPOTECAN-INDUCED SEVERE THROMBOCYTOPENIA - EVIDENCE FOR A REGRESSIVEINCIDENCE PATTERN ON SUCCESSIVE TREATMENT CYCLES (CY)
Authors: BUTHAUD X GOLDWASSER F GROSS M BLEUZEN P CVITKOVIC E JASMIN C MISSET JL
Citation: X. Buthaud et al., TOPOTECAN-INDUCED SEVERE THROMBOCYTOPENIA - EVIDENCE FOR A REGRESSIVEINCIDENCE PATTERN ON SUCCESSIVE TREATMENT CYCLES (CY), Annals of oncology, 9, 1998, pp. 258-258
CPT-11 OXALIPLATIN (L-OHP) COMBINATION - COMPARISON OF THE TOXICITY OF 2 SCHEDULES OF ADMINISTRATION/
Authors: GROSS M CVITKOVIC E WASSERMAN E GOLDWASSER F CHOUAKI N RIOFRIO M OULDKACI M TIGAUD JM MIGNARD D MISSET JL
Citation: M. Gross et al., CPT-11 OXALIPLATIN (L-OHP) COMBINATION - COMPARISON OF THE TOXICITY OF 2 SCHEDULES OF ADMINISTRATION/, Annals of oncology, 9, 1998, pp. 262-262
ECTEINASCIDIN-743 (ET-743) 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION (CI) PHASE-I STUDY IN SOLID TUMORS (ST) PATIENTS
Authors: CVITKOVIC E MEKRANTER B TAAMMA A GOLDWASSER F BEIJNEN JH JIMENO J RIOFRIO M VEGA E MISSET JL HOP P
Citation: E. Cvitkovic et al., ECTEINASCIDIN-743 (ET-743) 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION (CI) PHASE-I STUDY IN SOLID TUMORS (ST) PATIENTS, Annals of oncology, 9, 1998, pp. 456-456
PROTEIN-LINKED DNA BREAKS INDUCED BY ECTEINASCIDIN-743 IN HUMAN COLON-CARCINOMA CELLS
Authors: TAKEBAYASHI Y GOLDWASSER F POMMIER Y
Citation: Y. Takebayashi et al., PROTEIN-LINKED DNA BREAKS INDUCED BY ECTEINASCIDIN-743 IN HUMAN COLON-CARCINOMA CELLS, Annals of oncology, 9, 1998, pp. 531-531
IN-VITRO AND IN-VIVO RATIONATE FOR OXALIPLATIN IN COMBINATION WITH OTHER ANTITUMOR AGENTS
Authors: FAIVRE S RAYMOND E RIXE O GOLDWASSER F MANGOLD GL VONHOFF DD JUNIEWICZ P CVITKOVIC E
Citation: S. Faivre et al., IN-VITRO AND IN-VIVO RATIONATE FOR OXALIPLATIN IN COMBINATION WITH OTHER ANTITUMOR AGENTS, Annals of oncology, 9, 1998, pp. 554-554
EVIDENCE FOR ENHANCED TOXICITY TO CPT-11 IN PATIENTS WITH GILBERTS-SYNDROME - 2 CASE-REPORTS
Authors: WASSERMAN E MYARA A LOKIEC F KACI MO GOLDWASSER F MAGHERINI E CVITKOVIC E MISSET JL
Citation: E. Wasserman et al., EVIDENCE FOR ENHANCED TOXICITY TO CPT-11 IN PATIENTS WITH GILBERTS-SYNDROME - 2 CASE-REPORTS, European journal of cancer, 33, 1997, pp. 1130-1130
PACLITAXEL (TAXOL(R))-ASSOCIATED JUNCTIONAL TACHYCARDIA
Authors: FAIVRE S GOLDWASSER F SOULIE P MISSET JL
Citation: S. Faivre et al., PACLITAXEL (TAXOL(R))-ASSOCIATED JUNCTIONAL TACHYCARDIA, Anti-cancer drugs, 8(7), 1997, pp. 714-716
SEVERE CPT-11 TOXICITY IN PATIENTS WITH GILBERTS-SYNDROME - 2 CASE-REPORTS
Authors: WASSERMAN E MYARA A LOKIEC F GOLDWASSER F TRIVIN F MAHJOUBI M MISSET JL CVITKOVIC E
Citation: E. Wasserman et al., SEVERE CPT-11 TOXICITY IN PATIENTS WITH GILBERTS-SYNDROME - 2 CASE-REPORTS, Annals of oncology, 8(10), 1997, pp. 1049-1051
POTENTIATION OF CISPLATIN CYTOTOXICITY BY 9-AMINOCAMPTOTHECIN
Authors: GOLDWASSER F VALENTI M TORRES R KOHN KW POMMIER Y
Citation: F. Goldwasser et al., POTENTIATION OF CISPLATIN CYTOTOXICITY BY 9-AMINOCAMPTOTHECIN, Clinical cancer research, 2(4), 1996, pp. 687-693
DIFFERENTIAL GADD45, P21(C1P WAF1) MCL-1 AND TOPOISOMERASE-II GENE INDUCTION AND SECONDARY DNA FRAGMENTATION AFTER CAMPTOTHECIN-INDUCED DNA-DAMAGE IN 2 MUTANT P53 HUMAN COLON-CANCER CELL-LINES/
Authors: GOLDWASSER F BAE I FORNACE AJ POMMIER Y
Citation: F. Goldwasser et al., DIFFERENTIAL GADD45, P21(C1P WAF1) MCL-1 AND TOPOISOMERASE-II GENE INDUCTION AND SECONDARY DNA FRAGMENTATION AFTER CAMPTOTHECIN-INDUCED DNA-DAMAGE IN 2 MUTANT P53 HUMAN COLON-CANCER CELL-LINES/, Oncology research, 8(7-8), 1996, pp. 317-323
CORRELATIONS BETWEEN S AND G(2) ARREST AND THE CYTOTOXICITY OF CAMPTOTHECIN IN HUMAN COLON-CARCINOMA CELLS
Authors: GOLDWASSER F SHIMIZU T JACKMAN J HOKI Y OCONNOR PM KOHN KW POMMIER Y
Citation: F. Goldwasser et al., CORRELATIONS BETWEEN S AND G(2) ARREST AND THE CYTOTOXICITY OF CAMPTOTHECIN IN HUMAN COLON-CARCINOMA CELLS, Cancer research, 56(19), 1996, pp. 4430-4437
SUCCESSFUL CHEMOTHERAPY INCLUDING EPIRUBICIN IN A PREGNANT NON-HODGKINS-LYMPHOMA PATIENT
Authors: GOLDWASSER F PICO JL CERRINA J FERNANDEZ H PONS JC COSSET JM HAYAT M
Citation: F. Goldwasser et al., SUCCESSFUL CHEMOTHERAPY INCLUDING EPIRUBICIN IN A PREGNANT NON-HODGKINS-LYMPHOMA PATIENT, Leukemia & lymphoma, 20(1-2), 1995, pp. 173-176
THE ROLE OF CELL-CYCLE REGULATION AND APOPTOSIS TRIGGERING IN DETERMINING THE SENSITIVITY OF LEUKEMIC-CELLS TO TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS
Authors: DUBREZ L GOLDWASSER F GENNE P POMMIER Y SOLARY E
Citation: L. Dubrez et al., THE ROLE OF CELL-CYCLE REGULATION AND APOPTOSIS TRIGGERING IN DETERMINING THE SENSITIVITY OF LEUKEMIC-CELLS TO TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS, Leukemia, 9(6), 1995, pp. 1013-1024
CELLULAR PHARMACOLOGY OF AZATOXINS (TOPOISOMERASE-II AND TUBULIN INHIBITORS) IN P-GLYCOPROTEIN-POSITIVE AND P-GLYCOPROTEIN-NEGATIVE CELL-LINES
Authors: EYMIN B SOLARY E CHEVILLARD S DUBREZ L GOLDWASSER F DUCHAMP O GENNE P LETEURTRE F POMMIER Y
Citation: B. Eymin et al., CELLULAR PHARMACOLOGY OF AZATOXINS (TOPOISOMERASE-II AND TUBULIN INHIBITORS) IN P-GLYCOPROTEIN-POSITIVE AND P-GLYCOPROTEIN-NEGATIVE CELL-LINES, International journal of cancer, 63(2), 1995, pp. 268-275
TOPOISOMERASE I-RELATED PARAMETERS AND CAMPTOTHECIN ACTIVITY IN THE COLON-CARCINOMA CELL-LINES FROM THE NATIONAL-CANCER-INSTITUTE ANTICANCER SCREEN
Authors: GOLDWASSER F BAE I VALENTI M TORRES K POMMIER Y
Citation: F. Goldwasser et al., TOPOISOMERASE I-RELATED PARAMETERS AND CAMPTOTHECIN ACTIVITY IN THE COLON-CARCINOMA CELL-LINES FROM THE NATIONAL-CANCER-INSTITUTE ANTICANCER SCREEN, Cancer research, 55(10), 1995, pp. 2116-2121
GENISTEIN RESISTANCE IN HUMAN LEUKEMIC CCRF-CEM CELLS - SELECTION OF A DIPLOID-CELL LINE WITH REDUCED DNA TOPOISOMERASE-II BETA-ISOFORM
Authors: MARKOVITS J JUNQUA S GOLDWASSER F VENUAT AM LUCCIONI C BEAUMATIN J SAUCIER JM BERNHEIM A JACQUEMINSABLON A
Citation: J. Markovits et al., GENISTEIN RESISTANCE IN HUMAN LEUKEMIC CCRF-CEM CELLS - SELECTION OF A DIPLOID-CELL LINE WITH REDUCED DNA TOPOISOMERASE-II BETA-ISOFORM, Biochemical pharmacology, 50(2), 1995, pp. 177-186
THE CARDIOTOXICITY OF VINORELBINE
Authors: RAYMOND E GOLDWASSER F ESPIE M BRAIN E CUVIER C EXTRA JM MARTY M
Citation: E. Raymond et al., THE CARDIOTOXICITY OF VINORELBINE, Cancer research, therapy & control, 4(2), 1994, pp. 87-88
ADAMANTINOMA OF THE UPPER PART OF THE TIB IA - A CASE-REPORT
Authors: BRAIN EC RAYMOND E GOLDWASSER F EXTRA JM MARTY M
Citation: Ec. Brain et al., ADAMANTINOMA OF THE UPPER PART OF THE TIB IA - A CASE-REPORT, La Presse medicale, 23(33), 1994, pp. 1522-1526
MALIGNANT DISEASE METASTATIC TO THE EYE
Authors: RAYMOND E WALTER S GOLDWASSER F ESPIE M CUVIER C EXTRA JM MARTY M
Citation: E. Raymond et al., MALIGNANT DISEASE METASTATIC TO THE EYE, La Revue de medecine interne, 15(5), 1994, pp. 318-324
Risultati: 1-24 |